(Q33470365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

meta-analysis

0 references

title

Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Tian-Kang Guo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Bin Ma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ke-Hu Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yi-Ping Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hong-Ling Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yuan-Hui Gu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hui Cai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ya-Li Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yuan Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Wei-Peng Zhan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

18 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

1685-1692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19536563%20AND%20SRC:MED&resulttype=core&format=json

Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial

31 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0615-3

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0615-3

Regulatory peptide receptors in human hepatocellular carcinomas

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

1 reference

12 December 2020

Octreotide therapy for advanced hepatocellular carcinoma

1 reference

12 December 2020

Liver pathology and cell proliferation after octreotide administration following partial hepatectomy in rats: an experimental study

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma

1 reference

12 December 2020

1 reference

12 December 2020

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

12 December 2020

Systemic therapy for hepatocellular carcinoma

1 reference

12 December 2020

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

12 December 2020

Chemoembolization for hepatocellular carcinoma

1 reference

12 December 2020

Somatostatin analogs in the diagnosis and treatment of cancer

1 reference

12 December 2020

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

1 reference

12 December 2020

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

1 reference

12 December 2020

Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study

1 reference

12 December 2020

Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristics

1 reference

12 December 2020

Pharmacological therapy for portal hypertension: rationale and results.

1 reference

12 December 2020

Somatostatin analogs for cancer treatment and diagnosis: an overview

1 reference

12 December 2020

Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma

1 reference

12 December 2020

Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma

1 reference

12 December 2020

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

1 reference

12 December 2020

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

12 December 2020

Somatostatin analogs in oncology: a look to the future

1 reference

12 December 2020

Epidemiology of primary liver cancer

1 reference

12 December 2020

Somatostatin analogs and radiopeptides in cancer therapy

1 reference

12 December 2020

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

1 reference

12 December 2020

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

12 December 2020

Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection

1 reference

12 December 2020